Ultralife (ULBI) Capital Expenditures (2010 - 2026)

Ultralife's Capital Expenditures history runs 17 years deep, the most recent figure standing at $770000.0 for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 13.97% year-over-year to $770000.0 in Q1 2026; TTM through Mar 2026 was $299000.0, a 61.22% decrease from a year earlier, with the FY2025 full-year figure at $424000.0, up 70.97% from the prior year.
• Capital Expenditures rose to $770000.0 in Q1 2026 per ULBI's latest filing, from -$2.6 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $1.1 million in Q2 2025 and bottomed at -$2.6 million in Q4 2025.
• The 5-year median for Capital Expenditures is $516000.0 (2023), against an average of $254882.4.
• Across the five-year window, Capital Expenditures sank 315.71% in 2022 and surged 205.56% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at -$1.1 million in 2022, then soared by 195.08% to $1.0 million in 2023, then sank by 207.26% to -$1.1 million in 2024, then plunged by 138.03% to -$2.6 million in 2025, then surged by 130.01% to $770000.0 in 2026.
• Per Business Quant, the three latest ULBI Capital Expenditures figures stand at $770000.0 (Q1 2026), -$2.6 million (Q4 2025), and $995000.0 (Q3 2025).